Literature DB >> 20062077

SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition.

J A Kim1, J Lee, R L Margolis, R Fotedar.   

Abstract

Cell cycle controls ensure that DNA replication (S phase) follows mitosis resulting in two precise copies of the genome. A failure of the control mechanisms can result in multiple rounds of DNA replication without cell division. In endoreplication, cells with replicated genomes bypass mitosis, then replicate their DNA again, resulting in polyploidy. Endoreplication from G2 phase lacks all hallmarks of mitosis. Using synchronized cells, we show that the c-Jun N-terminal kinase (JNK) inhibitor, SP600125, prevents the entry of cells into mitosis and leads to endoreplication of DNA from G2 phase. We show that cells proceed from G2 phase to replicate their DNA in the absence of mitosis. This effect of SP600125 is independent of its suppression of JNK activity. Instead, the inhibitory effect of SP600125 on mitotic entry predominantly occurs upstream of Aurora A kinase and Polo-like kinase 1, resulting in a failure to remove the inhibitory phosphorylation of Cdk1. Importantly, our results directly show that the inhibition of Cdk1 activity and the persistence of Cdk2 activity in G2 cells induces endoreplication without mitosis. Furthermore, endoreplication from G2 phase is independent of p53 control.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20062077      PMCID: PMC3145494          DOI: 10.1038/onc.2009.464

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

Review 1.  Aurora-A - a guardian of poles.

Authors:  Tomotoshi Marumoto; Dongwei Zhang; Hideyuki Saya
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

2.  Ablation of the spindle assembly checkpoint by a compound targeting Mps1.

Authors:  Marc Schmidt; Yemima Budirahardja; Rob Klompmaker; René H Medema
Journal:  EMBO Rep       Date:  2005-09       Impact factor: 8.807

Review 3.  Polo-like kinases: a team that plays throughout mitosis.

Authors:  D M Glover; I M Hagan; A A Tavares
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

4.  MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

Authors:  J V Duncia; J B Santella; C A Higley; W J Pitts; J Wityak; W E Frietze; F W Rankin; J H Sun; R A Earl; A C Tabaka; C A Teleha; K F Blom; M F Favata; E J Manos; A J Daulerio; D A Stradley; K Horiuchi; R A Copeland; P A Scherle; J M Trzaskos; R L Magolda; G L Trainor; R R Wexler; F W Hobbs; R E Olson
Journal:  Bioorg Med Chem Lett       Date:  1998-10-20       Impact factor: 2.823

5.  Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.

Authors:  M J Hendzel; Y Wei; M A Mancini; A Van Hooser; T Ranalli; B R Brinkley; D P Bazett-Jones; C D Allis
Journal:  Chromosoma       Date:  1997-11       Impact factor: 4.316

6.  Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein.

Authors:  Thomas Jascur; Howard Brickner; Isabelle Salles-Passador; Valerie Barbier; Abdelhamid El Khissiin; Brian Smith; Rati Fotedar; Arun Fotedar
Journal:  Mol Cell       Date:  2005-01-21       Impact factor: 17.970

7.  Construction by gene targeting in human cells of a "conditional' CDC2 mutant that rereplicates its DNA.

Authors:  J E Itzhaki; C S Gilbert; A C Porter
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

8.  Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.

Authors:  A B Niculescu; X Chen; M Smeets; L Hengst; C Prives; S I Reed
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

9.  Role for cyclin A-dependent kinase in DNA replication in human S phase cell extracts.

Authors:  A Fotedar; D Cannella; P Fitzgerald; T Rousselle; S Gupta; M Dorée; R Fotedar
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

Review 10.  Polo-like kinases: positive regulators of cell division from start to finish.

Authors:  E A Nigg
Journal:  Curr Opin Cell Biol       Date:  1998-12       Impact factor: 8.382

View more
  35 in total

1.  Virtual target screening: validation using kinase inhibitors.

Authors:  Daniel N Santiago; Yuri Pevzner; Ashley A Durand; MinhPhuong Tran; Rachel R Scheerer; Kenyon Daniel; Shen-Shu Sung; H Lee Woodcock; Wayne C Guida; Wesley H Brooks
Journal:  J Chem Inf Model       Date:  2012-07-23       Impact factor: 4.956

Review 2.  Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors:  Juan Wang; Guixiang Tai
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

3.  Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor.

Authors:  John L Stebbins; Surya K De; Petra Pavlickova; Vida Chen; Thomas Machleidt; Li-Hsing Chen; Christian Kuntzen; Shinichi Kitada; Michael Karin; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2011-08-23       Impact factor: 7.446

4.  Enteral arginine modulates inhibition of AP-1/c-Jun by SP600125 in the postischemic gut.

Authors:  Kechen Ban; Rachel Santora; Rosemary A Kozar
Journal:  Mol Cell Biochem       Date:  2010-10-29       Impact factor: 3.396

5.  The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines.

Authors:  Taryn E Dick; Jeremy A Hengst; Todd E Fox; Ashley L Colledge; Vijay P Kale; Shen-Shu Sung; Arun Sharma; Shantu Amin; Thomas P Loughran; Mark Kester; Hong-Gang Wang; Jong K Yun
Journal:  J Pharmacol Exp Ther       Date:  2015-01-06       Impact factor: 4.030

6.  Involvement of stress kinase mitogen-activated protein kinase kinase 7 in regulation of mammalian circadian clock.

Authors:  Yoshimi Uchida; Tomomi Osaki; Tokiwa Yamasaki; Tadanori Shimomura; Shoji Hata; Kazumasa Horikawa; Shigenobu Shibata; Takeshi Todo; Jun Hirayama; Hiroshi Nishina
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

7.  Cdk1-mediated phosphorylation of Cdc7 suppresses DNA re-replication.

Authors:  James Knockleby; Byung Ju Kim; Avani Mehta; Hoyun Lee
Journal:  Cell Cycle       Date:  2016-04-22       Impact factor: 4.534

8.  Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-κB activation in neuronal and non-neuronal cells.

Authors:  Yadav Wagley; Cheol Kyu Hwang; Hong-Yiou Lin; Angel F Y Kam; Ping-Yee Law; Horace H Loh; Li-Na Wei
Journal:  Biochim Biophys Acta       Date:  2013-02-26

9.  Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.

Authors:  Francis R LeBlanc; Xin Liu; Jeremy Hengst; Todd Fox; Valerie Calvert; Emanuel F Petricoin; Jong Yun; David J Feith; Thomas P Loughran
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

10.  Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I.

Authors:  Xiao-Jing Shi; Lina Ding; Wenjuan Zhou; Yage Ji; Junwei Wang; Huimin Wang; Yongcheng Ma; Guozhong Jiang; Kai Tang; Yu Ke; Wen Zhao; Hong-Min Liu
Journal:  Antioxid Redox Signal       Date:  2016-11-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.